Rheumatoid Arthritis Therapeutics Market Expansion with Focus on Early Diagnosis
According to Fortune Business Insights, the global rheumatoid arthritis therapeutics market was valued at USD 32.49 billion in 2024. The market is projected to grow from USD 33.96 billion in 2025 to USD 43.83 billion by 2032, exhibiting a CAGR of 3.7% during the forecast period (2025–2032). In 2024, North America dominated the rheumatoid arthritis therapeutics market with a market share of 41.68%.
-
Follow
-
0
-
Embed
-
Share
-
Upload
